{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:42:53Z","timestamp":1792759373047,"version":"4.5.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T00:00:00Z","timestamp":1649635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T00:00:00Z","timestamp":1649635200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003810","name":"Hospital de Cl\u00ednicas de Porto Alegre","doi-asserted-by":"publisher","award":["180651"],"award-info":[{"award-number":["180651"]}],"id":[{"id":"10.13039\/501100003810","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Heart failure (HF) with reduced ejection fraction (HFrEF) is a syndrome that leads to fatigue and reduced functional capacity due to disease-related pathophysiological mechanisms. Aerobic exercise (AERO) plays a key role in improving HF outcomes, such as an increase in peak oxygen uptake (VO<jats:sub>2<\/jats:sub>peak). In addition, HF promotes cell senescence, which involves reducing telomere length. Several studies have shown that patients with a worse prognosis (i.e., reduced VO<jats:sub>2<\/jats:sub> peak) also have shorter telomeres. However, the effects of AERO on telomere length in patients with HFrEF are still unknown. In an attempt to fill this gap, we designed a study to determine the effects of 16\u2009weeks of aerobic training (32 sessions) on telomere length in HFrEF patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this single-center randomized controlled trial, men and women between 50 and 80\u2009years old will be allocated into two different groups: a moderate-intensity aerobic training and a control grouTelomere length, functional capacity, echocardiographic variables, endothelial function, and walking ability will be assessed before and after the 16-week intervention period.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>Understanding the role of physical exercise in biological aging in HFrEF patients is relevant. Due to cell senescence, these individuals have shown a shorter telomere length. AERO can delay biological aging according to a balance in oxidative stress through antioxidant action. Positive telomere length results are expected for the aerobic training group.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>ClinicalTrials.gov <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03856736\">NCT03856736<\/jats:ext-link>. Registered on February 27, 2019<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13063-022-06257-1","type":"journal-article","created":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T11:06:33Z","timestamp":1649675193000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Aerobic exercise and telomere length in patients with systolic heart failure: protocol study for a randomized controlled trial"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6327-1428","authenticated-orcid":false,"given":"Leandro T.","family":"Franzoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo L.","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie B.","family":"Motta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mabel M.","family":"Ahner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ot\u00e1vio A.","family":"Bertoletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco A. L.","family":"Saffi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anderson D.","family":"da Silveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre A.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adamastor H.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz C.","family":"Danzmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,11]]},"reference":[{"issue":"1","key":"6257_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.15420\/cfr.2016:25:2","volume":"3","author":"G Savarese","year":"2017","unstructured":"Savarese G, Lund LH. Global public health burden of heart failure. Card Fail Rev. 2017;3(1):7\u201311.","journal-title":"Card Fail Rev"},{"issue":"6","key":"6257_CR2","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/nrcardio.2016.25","volume":"13","author":"B Ziaeian","year":"2016","unstructured":"Ziaeian B, Fonarow GC. Epidemiology and aetiology of heart failure. Nat Rev Cardiol. 2016;13(6):368\u201378.","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"6257_CR3","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1152\/japplphysiol.00747.2017","volume":"124","author":"DC Poole","year":"2018","unstructured":"Poole DC, Richardson RS, Haykowsky MJ, Hirai DM, Musch TI. Exercise limitations in heart failure with reduced and preserved ejection fraction. J Appl Physiol (Bethesda, Md: 1985). 2018;124(1):208\u201324.","journal-title":"J Appl Physiol (Bethesda, Md: 1985)"},{"issue":"2","key":"6257_CR4","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.jacc.2017.11.025","volume":"71","author":"CW Yancy","year":"2018","unstructured":"Yancy CW, Januzzi JL Jr, Allen LA, et al. 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: answers to 10 pivotal issues about heart failure with reduced ejection fraction: a report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways. J Am Coll Cardiol. 2018;71(2):201\u201330.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"6257_CR5","doi-asserted-by":"publisher","first-page":"92","DOI":"10.2174\/157340308784245757","volume":"4","author":"KR Nilsson","year":"2008","unstructured":"Nilsson KR, Duscha BD, Hranitzky PM, Kraus WE. Chronic heart failure and exercise intolerance: the hemodynamic paradox. Curr Cardiol Rev. 2008;4(2):92\u2013100.","journal-title":"Curr Cardiol Rev"},{"issue":"17","key":"6257_CR6","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1016\/j.jacc.2019.01.072","volume":"73","author":"MG Del Buono","year":"2019","unstructured":"Del Buono MG, Arena R, Borlaug BA, et al. Exercise Intolerance in patients with heart failure: JACC state-of-the-art review. J Am Coll Cardiol. 2019;73(17):2209\u201325.","journal-title":"J Am Coll Cardiol"},{"issue":"141","key":"6257_CR7","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1183\/16000617.0048-2016","volume":"25","author":"BP Dube","year":"2016","unstructured":"Dube BP, Agostoni P, Laveneziana P. Exertional dyspnoea in chronic heart failure: the role of the lung and respiratory mechanical factors. Eur Respir Rev. 2016;25(141):317\u201332.","journal-title":"Eur Respir Rev"},{"issue":"5","key":"6257_CR8","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1161\/CIRCHEARTFAILURE.111.965186","volume":"5","author":"AM Swank","year":"2012","unstructured":"Swank AM, Horton J, Fleg JL, et al. Modest increase in peak VO2 is related to better clinical outcomes in chronic heart failure patients: results from heart failure and a controlled trial to investigate outcomes of exercise training. Circ Heart Fail. 2012;5(5):579\u201385.","journal-title":"Circ Heart Fail"},{"issue":"9","key":"6257_CR9","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1161\/01.CIR.99.9.1173","volume":"99","author":"R Belardinelli","year":"1999","unstructured":"Belardinelli R, Georgiou D, Cianci G, Purcaro A. Randomized, controlled trial of long-term moderate exercise training in chronic heart failure: effects on functional capacity, quality of life, and clinical outcome. Circulation. 1999;99(9):1173\u201382.","journal-title":"Circulation"},{"issue":"3","key":"6257_CR10","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1177\/2040622313480382","volume":"4","author":"C De Maeyer","year":"2013","unstructured":"De Maeyer C, Beckers P, Vrints CJ, Conraads VM. Exercise training in chronic heart failure. Ther Adv Chronic Dis. 2013;4(3):105\u201317.","journal-title":"Ther Adv Chronic Dis"},{"issue":"4","key":"6257_CR11","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3810\/psm.2011.11.1937","volume":"39","author":"CJ Chung","year":"2011","unstructured":"Chung CJ, Schulze PC. Exercise as a nonpharmacologic intervention in patients with heart failure. Physician Sports Med. 2011;39(4):37\u201343.","journal-title":"Physician Sports Med"},{"issue":"1","key":"6257_CR12","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1093\/eurheartj\/ehy585","volume":"40","author":"CM Werner","year":"2019","unstructured":"Werner CM, Hecksteden A, Morsch A, et al. Differential effects of endurance, interval, and resistance training on telomerase activity and telomere length in a randomized, controlled study. Eur Heart J. 2019;40(1):34\u201346.","journal-title":"Eur Heart J"},{"issue":"3","key":"6257_CR13","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/nrm2848","volume":"11","author":"RJ O\u2019Sullivan","year":"2010","unstructured":"O\u2019Sullivan RJ, Karlseder J. Telomeres: protecting chromosomes against genome instability. Nat Rev Mol Cell Biol. 2010;11(3):171\u201381.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"41","key":"6257_CR14","doi-asserted-by":"publisher","first-page":"7405","DOI":"10.1002\/anie.201002387","volume":"49","author":"EH Blackburn","year":"2010","unstructured":"Blackburn EH. Telomeres and telomerase: the means to the end (Nobel lecture). Angew Chem (Int Engl). 2010;49(41):7405\u201321.","journal-title":"Angew Chem (Int Engl)"},{"issue":"6265","key":"6257_CR15","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1126\/science.aab3389","volume":"350","author":"EH Blackburn","year":"2015","unstructured":"Blackburn EH, Epel ES, Lin J. Human telomere biology: a contributory and interactive factor in aging, disease risks, and protection. Science (New York, NY). 2015;350(6265):1193\u20138.","journal-title":"Science (New York, NY)"},{"issue":"13","key":"6257_CR16","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1016\/j.jacc.2007.01.027","volume":"49","author":"P van der Harst","year":"2007","unstructured":"van der Harst P, van der Steege G, de Boer RA, et al. Telomere length of circulating leukocytes is decreased in patients with chronic heart failure. J Am Coll Cardiol. 2007;49(13):1459\u201364.","journal-title":"J Am Coll Cardiol"},{"key":"6257_CR17","doi-asserted-by":"crossref","unstructured":"Sharifi-Sanjani M, Oyster NM, Tichy ED, et al. Cardiomyocyte-specific telomere shortening is a distinct signature of heart failure in humans. J Am Heart Assoc. 2017;6(9)","DOI":"10.1161\/JAHA.116.005086"},{"key":"6257_CR18","doi-asserted-by":"crossref","unstructured":"Reichert S, Stier A. Does oxidative stress shorten telomeres in vivo? Rev. 2017;13(12)","DOI":"10.1098\/rsbl.2017.0463"},{"issue":"7","key":"6257_CR19","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/S0968-0004(02)02110-2","volume":"27","author":"T von Zglinicki","year":"2002","unstructured":"von Zglinicki T. Oxidative stress shortens telomeres. Trends Biochem ences. 2002;27(7):339\u201344.","journal-title":"Trends Biochem ences"},{"key":"6257_CR20","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ebiom.2017.03.046","volume":"21","author":"J Jylhava","year":"2017","unstructured":"Jylhava J, Pedersen NL, Hagg S. Biol Age Predictors. EBioMedicine. 2017;21:29\u201336.","journal-title":"Biol Age Predictors. EBioMedicine"},{"key":"6257_CR21","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/978-981-13-2835-0_9","volume":"90","author":"G Saretzki","year":"2018","unstructured":"Saretzki G. Telomeres, telomerase and ageing. Sub-cellular Biochem. 2018;90:221\u2013308.","journal-title":"Sub-cellular Biochem"},{"issue":"6","key":"6257_CR22","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1097\/MCO.0000000000000506","volume":"21","author":"TM Freitas-Simoes","year":"2018","unstructured":"Freitas-Simoes TM, Ros E, Sala-Vila A. Telomere length as a biomarker of accelerated aging: is it influenced by dietary intake? Curr Opin Clin Nutr Metab Care. 2018;21(6):430\u20136.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"9","key":"6257_CR23","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1007\/s40279-016-0482-4","volume":"46","author":"J Denham","year":"2016","unstructured":"Denham J, O\u2019Brien BJ, Charchar FJ. Telomere length maintenance and cardio-metabolic disease prevention through exercise training. Sports Med (Auckland, NZ). 2016;46(9):1213\u201337.","journal-title":"Sports Med (Auckland, NZ)"},{"issue":"2","key":"6257_CR24","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1001\/archinternmed.2007.39","volume":"168","author":"LF Cherkas","year":"2008","unstructured":"Cherkas LF, Hunkin JL, Kato BS, et al. The association between physical activity in leisure time and leukocyte telomere length. Arch Intern Med. 2008;168(2):154\u20138.","journal-title":"Arch Intern Med"},{"issue":"5","key":"6257_CR25","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1093\/mutage\/gev038","volume":"30","author":"A Borghini","year":"2015","unstructured":"Borghini A, Giardini G, Tonacci A, et al. Chronic and acute effects of endurance training on telomere length. Mutagenesis. 2015;30(5):711\u20136.","journal-title":"Mutagenesis"},{"issue":"27","key":"6257_CR26","doi-asserted-by":"publisher","first-page":"45008","DOI":"10.18632\/oncotarget.16726","volume":"8","author":"NC Arsenis","year":"2017","unstructured":"Arsenis NC, You T, Ogawa EF, Tinsley GM, Zuo L. Physical activity and telomere length: impact of aging and potential mechanisms of action. Oncotarget. 2017;8(27):45008\u201319.","journal-title":"Oncotarget"},{"issue":"1","key":"6257_CR27","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2165\/00007256-200131010-00002","volume":"31","author":"LV Billat","year":"2001","unstructured":"Billat LV. Interval training for performance: a scientific and empirical practice. Special recommendations for middle- and long-distance running. Part I: aerobic interval training. Sports Med (Auckland, NZ). 2001;31(1):13\u201331.","journal-title":"Sports Med (Auckland, NZ)"},{"issue":"8","key":"6257_CR28","first-page":"2022","volume":"78","author":"JCS Joint Working Group","year":"2014","unstructured":"JCS Joint Working Group. Guidelines for rehabilitation in patients with cardiovascular disease (JCS 2012). Circ J Off J Jpn Circ Soc. 2014;78(8):2022\u201393.","journal-title":"Circ J Off J Jpn Circ Soc"},{"issue":"6","key":"6257_CR29","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1177\/2047487312449597","volume":"21","author":"MF Piepoli","year":"2014","unstructured":"Piepoli MF, Corra U, Adamopoulos S, et al. Secondary prevention in the clinical management of patients with cardiovascular diseases. Core components, standards and outcome measures for referral and delivery: a policy statement from the cardiac rehabilitation section of the European Association for Cardiovascular Prevention & Rehabilitation. Endorsed by the Committee for Practice Guidelines of the European Society of Cardiology. Eur J Prev Cardiol. 2014;21(6):664\u201381.","journal-title":"Eur J Prev Cardiol"},{"issue":"1","key":"6257_CR30","doi-asserted-by":"publisher","first-page":"e69","DOI":"10.1161\/CIR.0000000000000663","volume":"140","author":"RJ Thomas","year":"2019","unstructured":"Thomas RJ, Beatty AL, Beckie TM, et al. Home-based cardiac rehabilitation: a scientific statement from the American Association of Cardiovascular and Pulmonary Rehabilitation, the American Heart Association, and the American College of Cardiology. Circulation. 2019;140(1):e69\u201389.","journal-title":"Circulation"},{"issue":"9","key":"6257_CR31","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1249\/01.MSS.0000084522.14168.49","volume":"35","author":"M Collins","year":"2003","unstructured":"Collins M, Renault V, Grobler LA, et al. Athletes with exercise-associated fatigue have abnormally short muscle DNA telomeres. Med Sci Sports Exerc. 2003;35(9):1524\u20138.","journal-title":"Med Sci Sports Exerc"},{"issue":"2","key":"6257_CR32","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s00421-010-1353-6","volume":"109","author":"DE Rae","year":"2010","unstructured":"Rae DE, Vignaud A, Butler-Browne GS, et al. Skeletal muscle telomere length in healthy, experienced, endurance runners. Eur J Appl Physiol. 2010;109(2):323\u201330.","journal-title":"Eur J Appl Physiol"},{"issue":"11","key":"6257_CR33","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1093\/gerona\/glx037","volume":"72","author":"AH Shadyab","year":"2017","unstructured":"Shadyab AH, LaMonte MJ, Kooperberg C, et al. Association of accelerometer-measured physical activity with leukocyte telomere length among older women. J Gerontol Ser A Biol Sci Med Sci. 2017;72(11):1532\u20137.","journal-title":"J Gerontol Ser A Biol Sci Med Sci"},{"key":"6257_CR34","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.psyneuen.2018.08.002","volume":"98","author":"E Puterman","year":"2018","unstructured":"Puterman E, Weiss J, Lin J, et al. Aerobic exercise lengthens telomeres and reduces stress in family caregivers: a randomized controlled trial - Curt Richter Award Paper 2018. Psychoneuroendocrinology. 2018;98:245\u201352.","journal-title":"Psychoneuroendocrinology"},{"issue":"9","key":"6257_CR35","doi-asserted-by":"publisher","first-page":"e6393","DOI":"10.1590\/1414-431x20176393","volume":"50","author":"GA Ribeiro-Samora","year":"2017","unstructured":"Ribeiro-Samora GA, Rabelo LA, Ferreira ACC, et al. Inflammation and oxidative stress in heart failure: effects of exercise intensity and duration. Braz J Med Biol Res. 2017;50(9):e6393.","journal-title":"Braz J Med Biol Res"},{"key":"6257_CR36","doi-asserted-by":"publisher","first-page":"7239639","DOI":"10.1155\/2016\/7239639","volume":"2016","author":"N Sallam","year":"2016","unstructured":"Sallam N, Laher I. Exercise modulates oxidative stress and inflammation in aging and cardiovascular diseases. Oxid Med Cell Longev. 2016;2016:7239639.","journal-title":"Oxid Med Cell Longev"},{"key":"6257_CR37","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.3389\/fphys.2019.01123","volume":"10","author":"DD Gagnon","year":"2019","unstructured":"Gagnon DD, Dorman S, Ritchie S, et al. Multi-day prolonged low- to moderate-intensity endurance exercise mimics training improvements in metabolic and oxidative profiles without concurrent chromosomal changes in healthy adults. Front Physiol. 2019;10:1123.","journal-title":"Front Physiol"},{"key":"6257_CR38","doi-asserted-by":"crossref","unstructured":"Stoylen A, Conraads V, Halle M, Linke A, Prescott E, Ellingsen O, Controlled study of myocardial recovery after interval training in heart failure: SMARTEX-HF--rationale and design. Eur J Prev Cardiol, 2012. 19(4):813-821.","DOI":"10.1177\/1741826711403252"},{"issue":"12","key":"6257_CR39","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1161\/CIRCULATIONAHA.112.123117","volume":"126","author":"O Rognmo","year":"2012","unstructured":"Rognmo O, Moholdt T, Bakken H, et al. Cardiovascular risk of high- versus moderate-intensity aerobic exercise in coronary heart disease patients. Circulation. 2012;126(12):1436\u201340.","journal-title":"Circulation"},{"issue":"14","key":"6257_CR40","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1001\/jama.2009.454","volume":"301","author":"CM O\u2019Connor","year":"2009","unstructured":"O\u2019Connor CM, Whellan DJ, Lee KL, et al. Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. Jama. 2009;301(14):1439\u201350.","journal-title":"Jama"},{"key":"6257_CR41","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.canep.2018.07.012","volume":"56","author":"CM Friedenreich","year":"2018","unstructured":"Friedenreich CM, Wang Q, Ting NS, et al. Effect of a 12-month exercise intervention on leukocyte telomere length: results from the ALPHA Trial. Cancer Epidemiol. 2018;56:67\u201374.","journal-title":"Cancer Epidemiol"},{"key":"6257_CR42","doi-asserted-by":"crossref","unstructured":"Shephard RJ, Shek PN, Potential impact of physical activity and sport on the immune system--a brief review. Br J Sports Med, 1994. 28(4):247-255.","DOI":"10.1136\/bjsm.28.4.247"},{"issue":"3","key":"6257_CR43","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.biopsycho.2005.11.011","volume":"72","author":"Y Gidron","year":"2006","unstructured":"Gidron Y, Russ K, Tissarchondou H, Warner J. The relation between psychological factors and DNA-damage: a critical review. Biol Psychol. 2006;72(3):291\u2013304.","journal-title":"Biol Psychol"},{"key":"6257_CR44","doi-asserted-by":"crossref","unstructured":"Ding C, Cantor CR, Quantitative analysis of nucleic acids--the last few years of progress. J Biochem Mol Biol, 2004. 37(1):1-10.","DOI":"10.5483\/BMBRep.2004.37.1.001"},{"issue":"10","key":"6257_CR45","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/30.10.e47","volume":"30","author":"RM Cawthon","year":"2002","unstructured":"Cawthon RM. Telomere measurement by quantitative PCR. Nucleic Acids Res. 2002;30(10):e47.","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"6257_CR46","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/j.ahj.2015.01.017","volume":"169","author":"RM Nery","year":"2015","unstructured":"Nery RM, Zanini M, de Lima JB, Buhler RP, da Silveira AD, Stein R. Tai Chi Chuan improves functional capacity after myocardial infarction: a randomized clinical trial. Am Heart J. 2015;169(6):854\u201360.","journal-title":"Am Heart J"},{"issue":"9","key":"6257_CR47","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1161\/01.CIR.0000073597.57414.A9","volume":"108","author":"MD Cheitlin","year":"2003","unstructured":"Cheitlin MD, Armstrong WF, Aurigemma GP, et al. ACC\/AHA\/ASE 2003 guideline update for the clinical application of echocardiography: summary article: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (ACC\/AHA\/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). Circulation. 2003;108(9):1146\u201362.","journal-title":"Circulation"},{"issue":"30","key":"6257_CR48","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1093\/eurheartj\/ehz350","volume":"40","author":"DHJ Thijssen","year":"2019","unstructured":"Thijssen DHJ, Bruno RM, van Mil A, et al. Expert consensus and evidence-based recommendations for the assessment of flow-mediated dilation in humans. Eur Heart J. 2019;40(30):2534\u201347.","journal-title":"Eur Heart J"},{"issue":"3","key":"6257_CR49","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/sms.12652","volume":"27","author":"EP Monteiro","year":"2017","unstructured":"Monteiro EP, Franzoni LT, Cubillos DM, et al. Effects of Nordic walking training on functional parameters in Parkinson\u2019s disease: a randomized controlled clinical trial. Scand J Med Sci Sports. 2017;27(3):351\u20138.","journal-title":"Scand J Med Sci Sports"},{"issue":"5","key":"6257_CR50","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1249\/00005768-198205000-00012","volume":"14","author":"GA Borg","year":"1982","unstructured":"Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 1982;14(5):377\u201381.","journal-title":"Med Sci Sports Exerc"},{"issue":"7","key":"6257_CR51","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.jacbts.2019.05.009","volume":"4","author":"JK Yeh","year":"2019","unstructured":"Yeh JK, Lin MH, Wang CY. Telomeres as therapeutic targets in heart disease. JACC Basic Transl Sci. 2019;4(7):855\u201365.","journal-title":"JACC Basic Transl Sci"},{"issue":"4","key":"6257_CR52","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1083\/jcb.201610111","volume":"216","author":"P Mart\u00ednez","year":"2017","unstructured":"Mart\u00ednez P, Blasco MA. Telomere-driven diseases and telomere-targeting therapies. J Cell Biol. 2017;216(4):875\u201387.","journal-title":"J Cell Biol"},{"issue":"5","key":"6257_CR53","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1073\/pnas.1113306109","volume":"109","author":"BJ Heidinger","year":"2012","unstructured":"Heidinger BJ, Blount JD, Boner W, Griffiths K, Metcalfe NB. Monaghan Telomere length in early life predicts lifespan. Proc Natl Acad Sci U S A. 2012;109(5):1743\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"6257_CR54","doi-asserted-by":"publisher","first-page":"e92088","DOI":"10.1371\/journal.pone.0092088","volume":"9","author":"WL Chilton","year":"2014","unstructured":"Chilton WL, Marques FZ, West J, Kannourakis G, Berzins SP, O\u2019Brien BJ, et al. Acute exercise leads to regulation of telomere-associated genes and microRNA expression in immune cells. PLoS One. 2014;9(4):e92088.","journal-title":"PLoS One"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-022-06257-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-022-06257-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-022-06257-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T12:23:01Z","timestamp":1649679781000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-022-06257-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,11]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["6257"],"URL":"https:\/\/doi.org\/10.1186\/s13063-022-06257-1","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,11]]},"assertion":[{"value":"25 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This experiment will be conducted from March 2021 to December 2021. The study protocol was approved by the Institutional Review Board of Hospital de Cl\u00ednicas de Porto Alegre (protocol 180651, version 1) in August 2018. Prior to the evaluation process and after the study\u2019s objectives, the methods and the procedures for guaranteeing their anonymity are guaranteed and explained (including the use of the data only for scientific purposes); the participants will provide written informed consent to participate, as recommended by Resolution 466\/12 CNS\/MS. Prior to the study, the participants will be informed about how testing and training will take place. In addition, the importance of the data obtained during the study will also be pointed out.Both the research team and the institution will keep the identities of volunteers strictly confidential. The results of the procedures evaluated in the research will be analyzed and allocated in tables, figures, and\/or graphs and will be disseminated in lectures, conferences, scientific journals, or other media for transferring knowledge to society in accordance with the regulatory norms of national or international protection.The expected benefits will have great importance to participants, the institution involved, the researchers, society, and any other medium interested in advancing science, such as a better understanding of how TL behaves in patients with HFrEF, given its importance in cell senescence and the potential biomarker of disease prognosis. The expected results will demonstrate the effects of AERO on TL, which could contribute to improving rehabilitation programs and new research in the fields of exercise, cardiac rehabilitation, and health promotion.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"283"}}